Landos Biopharma, Inc. Current Ratio 2020-2024 | LABP

Landos Biopharma, Inc. current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $0.03B $0.01B 4.43
2023-12-31 $0.04B $0.01B 6.09
2023-09-30 $0.04B $0.01B 7.77
2023-06-30 $0.05B $0.00B 15.35
2023-03-31 $0.05B $0.00B 12.30
2022-12-31 $0.05B $0.01B 7.39
2022-09-30 $0.05B $0.01B 9.04
2022-06-30 $0.06B $0.01B 8.92
2022-03-31 $0.08B $0.02B 4.99
2021-12-31 $0.09B $0.02B 5.55
2021-09-30 $0.10B $0.01B 9.40
2021-06-30 $0.12B $0.01B 9.40
2021-03-31 $0.11B $0.01B 12.44
2020-12-31 $0.03B $0.01B 2.71
2020-09-30 $0.00B 0.00
2020-06-30 $0.00B 0.00
2020-03-31 $0.00B 0.00
2019-12-31 $0.05B $0.00B 16.56